Combination Therapy Offers CONFIDENCE to CKD+T2D Patients ...Middle East

Medscape - News
Combination Therapy Offers CONFIDENCE to CKD+T2D Patients
Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if backed by outcomes, herald a “new age” of care, suggests a landmark trial. Medscape Medical News

Hence then, the article about combination therapy offers confidence to ckd t2d patients was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Combination Therapy Offers CONFIDENCE to CKD+T2D Patients )

Apple Storegoogle play

Last updated :

Also on site :